-
Product Insights
NewMobidiag Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Mobidiag Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag's Prove-it products include prove-it sepsis, prove-it bone and joint, and prove-it herpes for...
-
Sector Analysis
Germany Infectious Disease Market Outlook to 2025
GlobalData’s “Germany Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Germany Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic...